Scientists at the University of Oxford in the UK have launched the first-in-human clinical trial to test a vaccine to protect people against deadly Nipah virus.Fifty-one people aged 18 to 55 will participate in the trial of the ChAdOx1 NipahB .
Scientists at the University of Oxford in the UK have launched the first-in-human clinical trial to test a vaccine to protect people against deadly Nipah virus.
Celebrating World Science day during November, a study has emphasised the success of the COVID Moonshot Consortium’s use of crowd sourcing and Open Science to accelerate its discovery of both a potent SARS-CoV-2 antiviral lead compound and the launch of a patent-free antiviral discovery program for rapid lead development in response to a pandemic emergency. Click to read more.
In their study published in Communications Biology, the team used a combination of fluorescence microscopy and artificial intelligence (AI) to detect antimicrobial resistance (AMR). This method relies on training deep-learning models to analyse bacte